Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem...

Area of Science:

• Cardiovascular Pharmacology
• Stem Cell Biology
• Drug Development

Background:

• Drug-induced cardiotoxicity is a major cause of drug attrition, necessitating improved preclinical safety assessment.
• Current reliance on animal models for cardiac safety assessment is limited by poor human translational specificity due to species differences.
• There is a critical need for reliable, efficient, and human-based models for preclinical cardiac safety evaluation.

Purpose of the Study:

• To detail methodologies for comprehensive functional assessment of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).
• To establish hiPSC-CMs as a valuable in vitro model for drug-induced cardiotoxicity screening and disease modeling.
• To highlight the potential of hiPSC-CMs to revolutionize preclinical cardiac safety assessment.

Main Methods:

• Utilizing human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as an in vitro model.
• Performing functional assays including contractility measurements.
• Assessing electrophysiological characteristics via field potential and action potential recordings.
• Investigating intracellular calcium handling dynamics.

Main Results:

• hiPSC-CMs provide a human-based model for assessing drug-induced cardiotoxicity.
• Methodologies for comprehensive functional characterization of hiPSC-CMs have been established.
• These assays allow for individual assessment of cardiotoxicity based on diverse genetic backgrounds.

Conclusions:

• hiPSC-CMs represent an invaluable tool for in vitro drug-induced cardiotoxicity screening.
• The use of hiPSC-CMs can significantly improve the predictive accuracy of preclinical cardiac safety assessments.
• Incorporating hiPSC-CMs into drug development pipelines has the potential to revolutionize the field.